Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 7, Pages 1772-1785
Publisher
Oxford University Press (OUP)
Online
2016-03-12
DOI
10.1093/jac/dkw045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne over Nine Years at a Large Italian Teaching Hospital
- (2015) Brunella Posteraro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review
- (2015) Hazem Elewa et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch Regimens in Immunocompromised Japanese Pediatric Patients
- (2014) Masaaki Mori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections
- (2014) Taotao Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity
- (2014) Michael J. Dolton et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Relationship between Trough Plasma and Epithelial Lining Fluid Concentrations of Voriconazole in Lung Transplant Recipients
- (2013) Siow-Chin Heng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
- (2013) Helen Y Chu et al. BMC INFECTIOUS DISEASES
- Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity
- (2013) Yosuke Suzuki et al. CLINICA CHIMICA ACTA
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
- (2013) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies
- (2013) Yeon-Joo Lee et al. MEDICAL MYCOLOGY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
- (2012) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS
- (2012) O. Lortholary et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
- (2012) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evaluation of the effect of obesity on voriconazole serum concentrations
- (2012) E. Koselke et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
- (2012) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients
- (2012) Alicia Gómez-López et al. MEDICAL MYCOLOGY
- Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
- (2012) Zdenek Racil et al. MYCOSES
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients
- (2011) Si-Hyun Kim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
- (2010) Andrew H. Limper et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients
- (2010) K. Han et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes
- (2009) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
- (2009) R. J. M. Bruggemann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Retrospective Serological Tests for Determining the Optimal Blood Concentration of Voriconazole for Treating Fungal Infection
- (2008) Toshikatsu OKUDA et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
- What Is the "Therapeutic Range" for Voriconazole?
- (2007) R. E. Lewis CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search